Issuer news 17237
02/29/2024 12:53 – Financial report
02/29/2024 12:53 – Financial report
02/29/2024 11:27 – Financial report
02/29/2024 11:27 – Financial report
02/29/2024 11:27 – Financial report
02/29/2024 11:26 – Financial report
02/29/2024 11:21 – Other information
02/29/2024 10:39 – Inside information
Double-digit growth in 2023 resulted in twice the amount of business compared to 2018 and confirmed the status of the largest domestically owned pharmaceutical company.
02/29/2024 10:01 – Inside information
02/29/2024 08:52 – Notification of the acquisition or disposal of own shares (art. 474. CMA) - Acquisition of shares
02/29/2024 08:38 – Other information
02/29/2024 08:37 – Inside information
02/29/2024 08:13 – Financial report
02/29/2024 08:13 – Financial report